Fecal calprotectin

2 papers1 finding

Human trial1
Humans1

Interventions

1

Semaglutide

no changein humans1

1 study

Semaglutide has no effect on fecal calprotectin in humans.
“No significant changes in hsCRP or calprotectin were observed.”
Human trialT2D on metformin1 mg weekly16 weeks
Semaglutide Improves Intestinal Barrier Function in T2D—A Double-Blind Randomized Controlled Trial (RCT)
ADA Scientific Sessions 2025 abstract13 Jun 2025

More on Semaglutide

Latest

4 in 12 months

Frontiers in Gastroenterology6 Sep

Glucagon like peptide 1 receptor agonists in patients with inflammatory bowel disease: safety, clinical effectiveness and anti-inflammatory mechanisms

ReviewGLP-1 receptor agonists

Digestive Diseases18 Aug

Using GLP-1 Receptor Agonists in Patients with Inflammatory Bowel Disease: A Systematic Review and Single-Arm Meta-Analysis

Meta-analysisGLP-1 receptor agonists

npj Aging3 Feb

Probiotic Lactiplantibacillus plantarum OL3246 supports healthy aging by enhancing quality of life, reducing inflammation, and modulating gut microbiota: a pilot study

Randomised trial in peopleGut and microbiome

Journal of Inflammation Research13 Nov

The Association Between Phenotypic Age and Primary Loss of Response to Biologic Agent in Patients with Crohn's Disease

Cohort study of 94 peopleBiomarkers

Biomedicines29 Oct

Inflammatory Insights: Analysis of a Fecal Biomarker in Neurodegenerative and Gastrointestinal Disorders

Cross-sectional study in peopleBiomarkers

ADA Scientific Sessions 2025 Abstract13 Jun

Semaglutide Improves Intestinal Barrier Function in T2D—A Double-Blind Randomized Controlled Trial (RCT)

Randomised trial in 46 peopleSemaglutide